• Customer portal
logo logo
  • Start
  • Products
    • Our products
    • Ultrasound
    • Radiography
    • MRI
    • Mammography
  • Pathology
    • Digital Pathology
    • INIFY™ Prostate
    • MasterAnnotation™
    • Advisory Board
    • Challenges
    • News
  • Technology
    • Our technology
    • Research & Development
    • The GOP technology
    • Artificial intelligence
  • News
    • News
    • Events
    • In the media
  • Investors
    • Investor news
    • Webcast
    • Financial reports
    • Corporate governance
    • Company overview
    • The share
    • Subscription
  • Company
    • About ContextVision
    • Management
    • Board of directors
    • Career
    • ContextVision quality policy
  • Contact
    • Sales Digital Pathology
    • Sales OEM Medical Imaging
    • OEM Medical Imaging
    • Investor relations & Media
    • Digital Pathology
    • Headquarters
  • HEJ!
    • Research & Development
    • Artificial intelligence
    • The GOP technology
logo logo
  • Start
  • Products
    • Our products
    • Ultrasound
    • Radiography
    • Magnetic Resonance Imaging
    • Mammography
  • Technology
    • Our technology
    • Research & Development
    • The GOP technology
    • Artificial intelligence
  • Pathology
    • Digital Pathology
    • INIFY™ Prostate
    • MasterAnnotation™
    • Advisory Board
    • Challenges
    • News
  • News
    • Latest news
    • Latest events
    • In the media
  • Investors
    • Investor news
    • Webcast
    • Financial reports
    • Corporate governance
    • Company overview
    • The share
    • Subscription
  • Company
    • About
    • Management
    • Board of Directors
    • Career
    • ContextVision quality policy
  • Contact
In The Media2013-08-02

Court Determines Intellectual Property in the Patent Application belongs to ContextVision

DOTmed.com July 15, 2013

Written by DOTmed.com staff writers.

Read more here.

Previous ContextVision wins patent lawsuit
Next New Ultrasound OEM Joins Roster of ContextVision Customers
© ContextVision AB (publ)